As of June 03, 2025, Beam Therapeutics (BEAM) has a market cap of $1.69 billion USD. According to our data, Beam Therapeutics is ranked No.4384 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jun 03, 2025 | $1.69 B |
-32.30%
|
Dec 31, 2024 | $2.49 B |
-8.89%
|
Dec 29, 2023 | $2.74 B |
-30.40%
|
Dec 30, 2022 | $3.93 B |
-50.92%
|
Dec 31, 2021 | $8.01 B |
-2.39%
|
Dec 31, 2020 | $8.21 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Editas Medicine
EDIT
|
$0.15 B |
-0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.27 B |
-0.000 M
|
![]() Switzerland
|
![]() Intellia Therapeutics
NTLA
|
$0.79 B |
-0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.12 B |
-0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$48.67 M |
0.000 M
|
![]() USA
|
![]() REGENXBIO
RGNX
|
$0.51 B |
0.000 M
|
![]() USA
|
![]() Precision BioSciences
DTIL
|
$57.60 M |
0.000 M
|
![]() USA
|
![]() Allogene Therapeutics
ALLO
|
$0.30 B |
0.000 M
|
![]() USA
|
![]() Sana Biotechnology
SANA
|
$0.53 B |
-0.000 M
|
![]() USA
|
![]() Verve Therapeutics
VERV
|
$0.43 B |
-0.000 M
|
![]() USA
|
![]() Cellectis
CLLS
|
$0.15 B |
43.672 M
|
![]() France
|
![]() Poseida Therapeutics
PSTX
|
$0.93 B |
0.000 M
|
![]() USA
|
Market Cap | = | BEAM Stock Price | * | BEAM Shares Outstanding |
= | $16.79 | * | 0.10 B | |
= | $1.69 B |